Although there is currently no direct evidence of DICER1 mutations in breast cancer, studies in other tumor types suggest that DICER1 mutations may contribute to tumor development through haploinsufficiency, which could potentially influence TMB. The gene discussed is DICER1; the disease is neoplasm.